Connect with us

Business

AstraZeneca hopes the world can focus on its positive vaccine news. But experts fear a lack of transparency has clouded that – CNN

When the British-Swedish drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine is 70% effective on average, the world exhaled a collective…

Published

on

post featured image
ADVERTISEMENT

(CNN)When the British-Swedish drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine is 70% effective on average, the world exhaled a collective sigh of relief and stocks rallied. Another vaccine with promising results had arrived.
But a lack of clarity surrounding several aspects of the data from the AstraZeneca vaccine trials have raised some eyebrows in the scientific community, potentially setting back the timing for the vaccine to be authorized in Europe and the…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Fauci: Joe Biden’s 100 million COVID-19 shots pledge means doses, not people – New York Post
post featured image
Aurinia’s FDA approval comes with label offering stronger patent protection – STAT
post featured image
Uber cuts 15 percent of Postmates’ workforce – Engadget